Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20151228025732N72
IRCT20151228025732N72
Recruiting
未知

Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsia

Semnan University of Medical Sciences0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHigh risk pregnancy.Supervision of high risk pregnancy

Overview

Phase
未知
Intervention
Not specified
Conditions
High risk pregnancy.
Sponsor
Semnan University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Semnan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Age 18 and above
  • •Body mass index above 30
  • •The interval between pregnancies is more than 10 years
  • •Multiple pregnancy
  • •Pre\-gestational diabetes
  • •Live singleton fetus

Exclusion Criteria

  • •Heart, liver, thyroid diseases, history of asthma
  • •Aspirin sensitivity
  • •Threatened abortion such as vaginal bleeding
  • •Eclampsia and pre\-eclampsia at the time of study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Vaginal Progesterone effect on pregnancy rate in infertility women with polycystic ovarian syndromeInfertility and Polycystic Ovarian Syndrome.Polycystic ovarian syndrome
IRCT201206072967N4Vice chancellor of research, Kashan University of Medical Sciences200
Completed
Phase 3
Evaluation of the effect of vaginal Progesterone in preventing preterm laborprevention of preterm labor.Preterm labour
IRCT138706051096N1Vice Chancellor for research-Guilan University of Medical Sciences260
Recruiting
Phase 3
Comparison of the effect of vaginal progesterone on uterine Doppler findings in early-onset preeclampsia
IRCT20210127050156N1Karaj University of Medical Sciences80
Active, not recruiting
Phase 1
The Effect of Vaginal Progesterone Administration in the prevention of Preterm Birth in Women with Short Cervix, [also Known as: Vaginal progesterone bioadhesive gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix-Trial (PREGNANT Short Cervix-Trial)] - PREGNANT Short Cervix-TrialPreterm birth (less than or equal to 32 6/7 weeks gestation)
EUCTR2008-007498-19-CZColumbia Laboratories, Inc450
Completed
Phase 2
effect of progestron in preterm laborpre term labor.Onset (spontaneous) of labour before 37 completed weeks of gestation
IRCT2014123120504N1Vice chancellor for research, Tehran University of Medical Sciences182